Riyadh - Sharikat Mubasher: Madeed, a Riyadh-based preventive health and longevity startup, secured $400,000 in a pre-seed funding round led by Vision Ventures, with participation from Saudi angel investors Mashhoor Aldubayan, Mazen Aldarrab, and Abdulla Nadeem Elyas.
Madeed will use the funding to finalize product development, expand clinical and laboratory partnerships across the region, and launch the first cohort of members, with an initial focus on Saudi Arabia, the company announced in a press release today.
Madeed is building the first longevity platform in the Middle East focused on true disease prevention and health optimization. It uses advanced laboratory testing to identify early risk signals across hundreds of diseases before symptoms appear.
The platform offers a membership-based model that combines diagnostics, physician-led interpretation, and personalized intervention. Members gain access to blood and biomarker testing, comprehensive health reports, and clinician-reviewed notes that translate complex data into clear insights across key domains such as metabolic health, hormone balance, cardiovascular risk, and inflammation.
Adam Bataineh, Founder and CEO of Madeed, said: “Healthcare in our region is still largely reactive. We built Madeed to flip that model using data, AI, and clinical oversight to help people optimize their health, understand risk early, and act decisively, long before disease takes hold.”
In turn, Kais Al Essa, Founding Partner and CEO of Vision Ventures, commented: “We are excited to partner with Dr. Adam by leading this funding round to build the region’s 1st longevity platform. We saw an evidence-based approach through Madeed, that is backed by science with Dr. Adam and his team. We believe it is time for the region to have better awareness and services around longevity and proactive care rather than reactive.”
In the long term, Madeed aims to become the default preventative health layer for the Middle East and beyond, combining diagnostics, intelligence, and interventions into a single, trusted longevity system.
